Variations in Inflammatory Biomarkers Following the Addition of Sitagliptin in Patients with Type 2 Diabetes not Controlled with Metformin

Arrigo F.G. Cicero, Pamela Maffioli, Giuseppe Derosa, Anna Carbone, Angela D'Angelo, Fabrizio Querci, Elena Fogari
  • Internal Medicine, January 2013, Japanese Society of Internal Medicine
  • DOI: 10.2169/internalmedicine.52.8175

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.2169/internalmedicine.52.8175

The following have contributed to this page: Dr Arrigo FG CICERO